Guidance document for industry - reporting adverse reactions to marketed health products : Canada Vigilance Adverse Reaction Monitoring Program and database, a program of MedEffect Canada. : H164-33/2011E-PDF
"This guidance document provides Market Authorization Holders (MAHs) with assistance on how to comply with the Food and Drugs Act, the Food and Drug Regulations, and the Natural Health Products Regulations with respect to reporting adverse reactions (ARs) to marketed health products. ARs for marketed health products within the scope of this guidance document are to be reported to the Canada Vigilance Adverse Reaction Monitoring Program of the Marketed Health Products Directorate (MHPD) of Health Canada"--Scope, p. 1.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.694177&sl=1
| Ministère/Organisme |
|
|---|---|
| Titre | Guidance document for industry - reporting adverse reactions to marketed health products : Canada Vigilance Adverse Reaction Monitoring Program and database, a program of MedEffect Canada. |
| Variante du titre |
|
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Édition ultérieure | Reporting adverse reactions to marketed health products |
| Édition précédente | Guidance document for industry - reporting adverse reactions to marketed health products |
| Format | Texte numérique |
| Document électronique | |
| Note(s) |
|
| Information sur la publication |
|
| Description | iv, 37 p. |
| ISBN | 978-1-100-17663-5 |
| Numéro de catalogue |
|
| Descripteurs |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.Détails de la page
- Date de modification :